Suppr超能文献

四种恶性肿瘤风险指数在恶性卵巢肿块检测中的比较。

Comparison of four malignancy risk indices in the detection of malignant ovarian masses.

机构信息

Obstetrics and Gynecology Department, Gulhane Military Medicine Academy, Ankara, Turkey.

出版信息

J Gynecol Oncol. 2011 Sep;22(3):177-82. doi: 10.3802/jgo.2011.22.3.177. Epub 2011 Sep 28.

Abstract

OBJECTIVE

The aim of this study was to evaluate the ability of four risk of malignancy indices (RMI) to detect malignant ovarian tumors.

METHODS

This is a prospective study of 100 women admitted to the Department of Obstetrics and Gynecology of Gulhane Military Medicine Academy for surgical exploration of pelvic masses. To diagnose malignant ovarian tumors, the sensitivity, specificity, negative and positive predictive values and diagnostic accuracy of four RMIs (RMI 1, RMI 2, RMI 3, and RMI 4) were obtained.

RESULTS

In our study we found that there is no statistically significant difference in the performance of four different RMIs in discriminating malignancy. We think that malignancy risk indices is more reliable than the menopausal status, serum CA-125 levels, ultrasound features and tumor size separately in detecting malignancy.

CONCLUSION

We concluded that any of the four malignancy risk indices described can be used for selection of cases for optimal therapy. These methods are simple techniques that can be used even in less-specialized gynecology clinics to facilitate the selection of cases for referral to an oncological unit.

摘要

目的

本研究旨在评估四种恶性肿瘤风险指数(RMI)检测卵巢恶性肿瘤的能力。

方法

这是一项对 100 名因盆腔肿块接受古尔哈内军事医学院妇产科手术探查的女性进行的前瞻性研究。为了诊断卵巢恶性肿瘤,我们获得了四种 RMIs(RMI1、RMI2、RMI3 和 RMI4)的敏感性、特异性、阴性和阳性预测值及诊断准确性。

结果

在我们的研究中,我们发现四种不同的 RMIs 在鉴别恶性肿瘤方面的性能没有统计学差异。我们认为,在检测恶性肿瘤方面,恶性肿瘤风险指数比绝经状态、血清 CA-125 水平、超声特征和肿瘤大小更为可靠。

结论

我们得出结论,所描述的四种恶性肿瘤风险指数中的任何一种都可用于选择最佳治疗的病例。这些方法是简单的技术,即使在不太专业的妇科诊所也可以使用,以便于选择转介到肿瘤学单位的病例。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d075/3188716/a2b04fb10db2/jgo-22-177-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验